[F-18]-FDG-PET as an early response predictor in a HER-2 overexpressing, trastuzumab-resistant breast cancer model treated with targeted PI3K/Akt/mTOR drugs
Journal article published in 2015 by
Y. Dockx,
C. Vangestel,
S. De Bruycker 
,
M. Huizing,
P. Pauwels,
T. Van den Wyngaert,
S. Staelens,
S. Stroobants
,
M. Huizing,
P. Pauwels,
T. Van den Wyngaert,
S. Staelens,
S. Stroobants
